
SGLT2 Inhibitors: A New TAVI Standard
Summary SGLT2 inhibitors, like dapagliflozin, significantly improve outcomes for high-risk older adults undergoing transcatheter aortic valve implantation (TAVI). A recent study showed a marked reduction in mortality and heart failure events in patients receiving dapagliflozin. […]